We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGLD icon
251
Royal Gold
RGLD
$22.2B
$294K ﹤0.01%
+1,472
New +$342K
VSAT icon
252
Viasat
VSAT
$10.4B
$290K ﹤0.01%
+3,230
New +$214K
LPX icon
253
Louisiana-Pacific
LPX
$4.77B
$288K ﹤0.01%
+3,660
New +$270K
WBD icon
254
Warner Bros
WBD
$70.8B
$287K ﹤0.01%
+10,767
New +$291K
OTEX icon
255
Open Text
OTEX
$5.8B
$283K ﹤0.01%
+12,774
New +$290K
PWCM
256
PowerCompute Inc
PWCM
$2.12M
$278K ﹤0.01%
74,362
+30,476
+69% +$178K
JOE icon
257
St. Joe Company
JOE
$3.76B
$274K ﹤0.01%
+4,370
New +$287K
TXNM
258
TXNM Energy Inc
TXNM
$5.98B
$268K ﹤0.01%
+4,713
New +$276K
ARCC icon
259
Ares Capital
ARCC
$14.4B
$263K ﹤0.01%
+14,191
New +$265K
ATMU icon
260
Atmus Filtration Technologies
ATMU
$3.94B
$262K ﹤0.01%
+5,141
New +$279K
OWL icon
261
Blue Owl Capital
OWL
$8.04B
$262K ﹤0.01%
29,898
-18,123
-38% -$172K
IMNN icon
262
Imunon
IMNN
$8.87M
$258K ﹤0.01%
144,767
-203,563
-58% -$502K
AJG icon
263
Arthur J. Gallagher & Co
AJG
$67.3B
$256K ﹤0.01%
+1,113
New +$236K
WTRG icon
264
Essential Utilities
WTRG
$11.8B
$253K ﹤0.01%
+6,604
New +$252K
SOFI icon
265
SoFi Technologies
SOFI
$23.5B
$250K ﹤0.01%
+13,954
New +$236K
PJT icon
266
PJT Partners
PJT
$4.67B
$250K ﹤0.01%
+1,656
New +$255K
MTEKW icon
267
Maris-Tech Ltd Warrants
MTEKW
$246K ﹤0.01%
1,261,058
– –
CAKE icon
268
Cheesecake Factory
CAKE
$5.35B
$242K ﹤0.01%
+3,043
New +$197K
CLH icon
269
Clean Harbors
CLH
$16.7B
$242K ﹤0.01%
+810
New +$239K
PPL
270
PPL Corp
PPL
$26.4B
$240K ﹤0.01%
+6,598
New +$244K
GLNG icon
271
Golar LNG
GLNG
$5.32B
$237K ﹤0.01%
+4,760
New +$252K
HGV icon
272
Hilton Grand Vacations
HGV
$3.27B
$237K ﹤0.01%
+4,529
New +$218K
NNN icon
273
NNN REIT
NNN
$8.57B
$231K ﹤0.01%
+4,968
New +$222K
AHR icon
274
American Healthcare REIT
AHR
$11.9B
$231K ﹤0.01%
+4,424
New +$217K
CRCL
275
Circle Internet Group
CRCL
$25.9B
$230K ﹤0.01%
+3,677
New +$358K
9 10
11
12 13

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.